alexa
Reach Us +441902928240
Editor - Dr. Francesco Angelini | IRCCS Centro di Riferimento On | 26783
ISSN: 2157-7633

Journal of Stem Cell Research & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Dr. Francesco Angelini

Dr. Francesco Angelini
Dr. Francesco Angelini Research Fellow/Clinical Study Coordinator
Medical Oncology Unit
San Filippo Neri Hospital
Via Giovanni Martinotti
Roma, Italy Department of Sperimental and Clinic Pharmacology
IRCCS Centro di Riferimento Oncologico
Via Franco Gallini
Aviano, Italy

Biography

Dr. Francesco Angelini holds a Ph.D. degree in Pasteurian Sciences, an M.S. degree in pharmaceutical biotechnology, and a B.S. degree in biotechnology. Angelini has worked as a Postdoc Research Fellow at the Faculty of Pharmacy and Medicine, Department of Medical Surgical Sciences and Biotechnology, "La Sapienza" University of Rome, Rome, Italy. Angelini currently serves as a Research Fellow in the Horizon 2020 Project "U-PGx-Ubiquitous Pharmacogenomics: Making Actionable Pharmacogenomic Data and Effective Treatment Optimization Accessible to Every European Citizen," SOC Farmacologia Sperimentale e Clinica, Dipartimento della Ricerca e della Diagnostica Avanzata dei Tumori, CRO Aviano (Italy), and UOC Oncologica, Ospedale San Filippo Neri, Roma (Italy). Angelini’s current research interests include pharmacogenomics, tumor microenvironment, circulating tumor cells, resident cardiac progenitor cells, stem cell therapy for heart disease, and tissue engineering.

Research Interest

Stem cells; Regenerative medicine; Exosomes; Cancer; Pharmacogenomics

Leave Your Message 24x7
Top